abstract |
DETAILED DESCRIPTION The present invention relates to novel tetralral based amines and central nervous system (CNS) disorders such as depression, attention deficit hyperctivity disorder (ADHD) and Parkinson's disease. To their use in therapy.n n n In addition, the present invention provides a pharmaceutical composition containing a compound of the present invention, and reuptake of one or more monoamines, such as dopamine and norepinephrine, in the composition and synaptic cleft of the present invention. ) Is a method of inhibiting). |